Company intelligence / Profile preview
BnH Research
Goyang-si, Gyeonggi-do, South Koreabnhresearch.net ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
BnH Research is a South Korea-based biopharmaceutical company focused on developing therapeutics for chronic conditions, particularly central nervous system (CNS) disorders. Its lead programs are in preclinical stages, with at least one candidate targeting autism spectrum disorder and another as an hdac6 inhibitor for CNS diseases such as Alzheimer's disease. The company has recently secured significant Series B funding to advance its pipeline
- Therapeutic areas
- PsychiatryOphthalmologyNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
CMC agreement with Wuxi, China (manufacturing partner)GLP agreement with LSSI, Japan (preclinical/GLP services)
Beyond the preview
Go deeper on BnH Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BnH Research.